Blood-Borne Diseases

Researchers at the University of North Carolina at Chapel Hill have found out how hepatitis A causes acute liver injury.

In a collaborative effort, researchers have discovered what they refer to as a “Trojan Horse” strategy that uses two developed bispecific antibodies that have proved active against all five strains of the ebolavirus.

John D'Angelo, MD, senior vice president, executive director of Emergency Medicine Services at Northwell Health, describes the importance for hospital staff to be prepared for outbreaks.

A new study has shown that infected wild house mice will disengage from their social groups, resulting in a decreased potential for disease transmission; these findings can be applied to improve models used to predict transmission of infectious diseases spread by social contact, such as Ebola and influenza.

Researchers from Nanjing Biopoint have made a breakthrough when it comes to fighting HIV through the development of a product that uses certain material when collecting blood samples that can separate the plasma from the rest of the blood, allowing the sample to be safely sent to a testing center.

A new report from Liberia’s Men’s Health Screening Program provides insight into the persistence of the Ebola virus in the semen of survivors.

As sporadic cases of Ebola continue to arise in West Africa, a controversial approach could be utilized to increase survival rates in those who are infected.

Researchers from the Copenhagen University Hospital of Denmark find that individuals who are hospitalized with infections have an increased risk of suicide ideation and death; individuals infected with hepatitis and HIV or AIDS have the highest risk of suicide-related death.

The Virginia Department of Health has issued a warning stating that there is an increased risk of hepatitis A in the state of Virginia that may potentially link back to frozen strawberries sourced from Egypt.

A traceback investigation has found that raw scallops have contributed to the hepatitis A outbreak in Hawaii.

A new study conducted by an Ebola diagnostic laboratory in Liberia has found that there is a connection between the survival of individuals with Ebola and co-infection with Plasmodium parasites that cause malaria.

Mirus Bio, a spinoff company from the University of Wisconsin-Madison, has developed a method for “silencing” RNA against hepatitis B (HBV) that has reached clinical trials in Asia, Europe, and the United States.

With the assistance of funds granted by Congress, the Department of Veteran Affairs (VA) will extend new hepatitis C (HCV) treatment to all infected veterans within their healthcare system, of all stages of illness and regardless of whether or not the infection had been acquired during military service.

In response to an increase of hepatitis C cases in Rhode Island that have resulted in hospitalizations and deaths, the Rhode Island Department of Health and the Rhode Island Public Health Institute have worked together to compose their first ever, comprehensive epidemiological report.

Collateral damage from the ongoing opioid abuse epidemic in the United States continues to plague many rural communities across the country, with recent reports suggesting it is likely behind clusters of HIV cases in these areas.

A new study has confirmed that significantly more women than men diagnosed with Staphylococcus aureus bacteraemia will die within 30 days of acquiring the infection.

Through the use of targeted screening programs, the ECDC has found that foreign-born migrants are at a higher risk of hepatitis B and C. Identifying risk groups can help practitioners reduce the burden of chronic hepatitis.

The US Food and Drug Administration has approved VIEKIRA XR, the first co-formulated three direct-acting antiviral for adults diagnosed with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection.

CDC Public Health Response Director Warns Lack of Funds Hampers Protection Efforts

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response, at the Centers for Disease Control and Prevention explains what they learned from handling the response to the Ebola outbreak in 2014-2015.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) explains what the CDC learned from responding to the Ebola outbreak and how this has impacted the response to the Zika virus.

Those patients who survive infections caused by the Ebola or Marburg viruses may gain at least partial immunity to other filoviruses through specific antibodies generated during serological immune responses.

The Hawaii State Department has confirmed an open investigation of the hepatitis A infection in Oahu, Hawaii.

A new study may uncover the mystery behind why the Ebola virus disease is fatal to only some, and lead to pathways to new treatments.

This review article provides guidance for clinicians that have been struggling with the most effective way to treat chronic hepatitis B virus (HBV) infection in children and adolescents.